{"id":"W2057039211","doi":"10.3747/co.22.2430","title":"Management of egfr tki—Induced Dermatologic Adverse Events","year":2015,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Lakeridge Health; BC Cancer Agency; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"Johnson and Johnson; Janssen Biotech; Astellas Pharma; AstraZeneca; Celgene; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Paronychia; Adverse effect; Dermatology; Gefitinib; Rash; Erlotinib; Epidermal growth factor receptor; EGFR inhibitors; Lung cancer; Clinical trial; Chemotherapy; Cancer; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005563529,0.0005629867,0.001179885,0.001667937,0.0002092323,0.0006442554,0.0007138161,0.0007332832,0.003434376],"category_scores_gemma":[0.0007864956,0.0001561962,0.000901491,0.001133865,0.0002319893,0.000614212,0.0004326795,0.001029016,0.0009217159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003508478,"about_ca_system_score_gemma":0.0007235011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006490821,"about_ca_topic_score_gemma":0.00163712,"domain_scores_codex":[0.9997472,0.00005821526,0.00004848982,0.00002936679,0.00009761829,0.00001905261],"domain_scores_gemma":[0.9996823,0.0001574428,0.00007551331,0.000007690408,0.00006199784,0.00001505222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005392155,0.00007135969,0.0001968805,0.0392624,0.0001880278,0.0002133365,0.00005260278,0.0002155731,0.0009257473,0.001185435,0.01630352,0.9413312],"study_design_scores_gemma":[0.00006846849,0.0001816855,0.0026279,0.02265123,0.0005972779,0.004323335,0.0001188001,0.0001670606,0.0009583805,0.001754492,0.9665253,0.000026141],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002095737,0.9984269,0.0001146091,0.0001901509,0.000077248,0.00001209201,0.00002165561,0.000005686247,0.0009421149],"genre_scores_gemma":[0.001449525,0.997663,0.0002256064,0.0001717741,0.00007566316,0.0000110404,0.00003420718,0.000001091337,0.0003680851],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003434376,"threshold_uncertainty_score":0.01148915,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.265417522412585,"score_gpt":0.5492822625137567,"score_spread":0.2838647401011716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}